List of Metacrine patents | 8 results

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11084817 Farnesoid X receptor agonists and uses thereof	Patent 11084817 was granted and assigned to Metacrine on August, 2021 by the United States Patent and Trademark Office.	Metacrine	Metacrine	United States Patent and Trademark Office	11084817	August 10, 2021
‌ US Patent 10927082 Farnesoid X receptor agonists and uses thereof	Patent 10927082 was granted and assigned to Metacrine on February, 2021 by the United States Patent and Trademark Office.	Metacrine	Metacrine	United States Patent and Trademark Office	10927082	February 23, 2021
‌ US Patent 11236071 Farnesoid X receptor agonists and uses thereof	Patent 11236071 was granted and assigned to Metacrine on February, 2022 by the United States Patent and Trademark Office.	Metacrine	Metacrine	United States Patent and Trademark Office	11236071	February 1, 2022
‌ US Patent 10626081 Farnesoid X receptor agonists and uses thereof	Patent 10626081 was granted and assigned to Metacrine on April, 2020 by the United States Patent and Trademark Office.	Metacrine	Metacrine	United States Patent and Trademark Office	10626081	April 21, 2020
‌ US Patent 11214538 Farnesoid X receptor agonists and uses thereof	Patent 11214538 was granted and assigned to Metacrine on January, 2022 by the United States Patent and Trademark Office.	Metacrine	Metacrine	United States Patent and Trademark Office	11214538	January 4, 2022
‌ US Patent 10377717 Farnesoid X receptor agonists and uses thereof	Patent 10377717 was granted and assigned to Metacrine on August, 2019 by the United States Patent and Trademark Office.	Metacrine	Metacrine	United States Patent and Trademark Office	10377717	August 13, 2019
‌ US Patent 10961198 Farnesoid X receptor agonists and uses thereof	Patent 10961198 was granted and assigned to Metacrine on March, 2021 by the United States Patent and Trademark Office.	Metacrine	Metacrine	United States Patent and Trademark Office	10961198	March 30, 2021
‌ US Patent 10703712 Farnesoid X receptor agonists and uses thereof	Patent 10703712 was granted and assigned to Metacrine on July, 2020 by the United States Patent and Trademark Office.	Metacrine	Metacrine	United States Patent and Trademark Office	10703712	July 7, 2020